Top 4 Ways Health Systems Benefit from An API Approach to Clinical Surveillance

Speed is one of the most essential attributes of an effective approach to clinical surveillance. The faster patient data can be pulled from the EMR and sorted by clinical surveillance technology, the more quickly physicians and pharmacists can receive targeted alerts that lead to more optimal patient care decisions.

These alerts might be related to the identification of potential medication errors, the inappropriate use of antibiotics, or a possible outbreak of an infection such as C. diff.

To read about how health systems are using clinical surveillance to enhance patient care, read  “Clinical Surveillance: The Next Step in Value-Based Care.”

At the recent HIMSS Conference in Orlando, Adam Klass, chief technology officer at VigiLanz, and Dave Levin, MD, chief medical officer, Sansoro Health, spoke about how application programming interfaces (APIs) can be a gamechanger in clinical surveillance because they help data flow between EMRs and clinical surveillance solutions more quickly.

To view their full presentation, click here.

“We’re dealing with really important clinical problems here, and the sooner we can get these solutions in place and begin to impact the outcomes, the better for everyone,” said Levin.

APIs vs. HL7

For many years, most healthcare systems have transferred data from EMRs to outside solutions, such as clinical surveillance technology, via HL7 interfaces. But there are some drawbacks to this approach.

According to Klass:

  • The HL7 standard is interpreted in many different ways, which can raise confusion.
  • Hospital IT departments must spend time validating transferred data to ensure it is exchanging properly.
  • The approach requires building interfaces and maintaining them, which can be costly and time-consuming.

API data acquisition and transfer, on the other hand, provides a “more unified” data model, Klass said.  Information is pulled from the EMR in near real time, in a standard format, and it’s always sent to partners the same way, regardless of the EMR from which it originates.

“The value as you build out a full API footprint is getting that full clinical model from Day 1, so you’re not having to circle back to healthcare organizations to gather more data over time,” Klass said. “The hospital IT team involvement becomes significantly less as you use these APIs. The cost is also significantly less because you remove the maintenance and support that goes into supporting interfaces.”

Growing movement

More and more hospitals are recognizing the benefits of the API approach to data transfer. In fact, 30 health systems are already using APIs to exchange EMR data with VigiLanz’s platform, and many more are starting to implement the technology, said Klass.

He cited the following four benefits:

  • Less hospital IT department time spent on clinical surveillance.
  • Reduced hospital costs associated with clinical surveillance (hospitals no longer need to build interfaces, oversee numerous file transfers, or bring in consultants to assist with the work).
  • Faster implementations.
  • Broader accessibility for providers to clinical surveillance tools immediately after implementation.

Levin agrees. “An API approach to integration greatly reduces the amount of time that’s required to deploy the [clinical surveillance] solution and that translates into a cost savings,” he said. “But more importantly, it translates into a better user experience, a richer data set that takes a product that’s already really good and makes it even better.”

HIMSS Quoteables: Highlights from VigiLanz’s HIMSS Presentations

The 2019 HIMSS Conference, held February 11 to 15 in Orlando, shed light on some of the most exciting developments in the health IT space.

For us, the conference had many high points, including the unveiling of our latest report: “Clinical Surveillance: The Next Step in Value-Based Care.” The report, based on a survey of 100 healthcare executives, reveals where hospitals are in the journey to higher value care, and how they are using data analytics, EMRs, and clinical surveillance tools to support their efforts.

During the conference, several members of our leadership team presented on the topic of clinical surveillance, as did several hospital leaders whose health systems are currently using our technology. Here are a few of our favorite quotes from their presentations:

Nicholas Desai, MD

Nicholas Desai, MD, system chief medical information officer at Houston Methodist Hospital, on how physicians are responding to IllumiCare’s Smart Ribbon, which integrates alerts, such as those provided by VigiLanz, into the EMR. For more of Desai’s thoughts, click here.

“I can call [the Smart Ribbon] up when I want it. I can force it to be active or passive. I engage how I want it. We shared this [tool] with about 145 doctors and providers … at the end of the 90-day pilot, not only did we shift the curve, but 72% of doctors at the end of our pilot said, ‘This is not just valuable, finally you’re giving me a tool that is meaningful.’ In every one of those conversations, cost was important but not the only reason why they liked the tool. What they liked about it was that it allowed them to see things in a more holistic view in one place.”

We were able to shift the cost curve within the 90-day mark about $107,000. Overall, we believe that in 2019 for this hospital, we have an opportunity of 4.5% reduction in our costs, which will lead to $1.7 million and $2.8 million, just for one hospital. As an organization, this could be closer to in the ballpark of $18-, $19-, $20 million dollars. It did nothing but present information in a very consumable format.”

Bart Abban, PhD

Bart Abban, PhD, director analytics and data science, VigiLanz, also speaking about the value the Illumicare-VigiLanz partnership brings to providers. For more of Abban’s thoughts, click here.

“You can send this information straight into the purview of the doctor with our partnership with [Illumicare]. So if you want to stay in Cerner or another EMR tool that you use, you don’t have to enter our system, we can send it right to the system the physicians are working on.”

Dave Levin, MD

Dave Levin, MD, chief medical officer, Sansoro Health, on the benefits API integration is bringing his healthcare system related to clinical surveillance and data exchange. For more of Levin’s thoughts, click here.

An API approach to integration greatly reduces the amount of time that’s required to deploy the [clinical surveillance] solution, and that translates into cost saving. But more importantly, it translates into a better user experience, a richer data set that takes a product that’s already really good and makes it even better … We’re dealing with really important clinical problems here, and the sooner we can get these solutions in place and begin to impact the outcomes, the better for everyone.”

This is really not about APIs, it’s about solving important business and clinical problems. I think the VigiLanz-Sansoro partnership is probably one of the best examples anywhere in healthcare right now about how this can work.”

Adam Klass

Adam Klass, chief technology officer, VigiLanz, also speaking about the value of APIs in clinical surveillance. For more of Klass’ thoughts, click here.

“The value, as you build out a full API footprint, is getting that full clinical model from Day 1, so you’re not having to circle back to healthcare organizations to gather more data over time. The hospital IT team involvement becomes significantly less as you use these APIs. The cost is also significantly less because you remove the maintenance and support that goes into supporting interfaces.”

“We’re listening for things like your admissions, discharges, and transfers; your medication orders; your lab test reorders; preliminary and final micro susceptibility results, drug administrations, procedures, and surgeries. The more information that can come into the VigiLanz private cloud, the more types of things we can do around surveillance of that data.”

Bart Abban, PhD

Abban, speaking about how VigiLanz is providing physicians with predictive analytics that can improve patient care and prevent problems from escalating. For more of his thoughts, click here.

“There are several companies around here selling point-solution singular products [for predictive analytics]. With our platform you can do readmissions today, tomorrow you can start looking at mortality risk, you can look at adverse events, glycemic control. We are currently developing a model on C. diff to alert clinicians to patients who are at high risk of getting C. diff. The sky is the limit.”

IllumiCare and VigiLanz Partner to Help Pharmacists and Clinicians Advance Antimicrobial Stewardship

Houston Methodist Sugar Land Hospital first in country to launch new point-of-care alert solution with pharmacist-only rollout.

BIRMINGHAM, HOUSTON, & MINNEAPOLIS – February 6, 2018 – The CDC estimates that 20 to 50 percent of antibiotics prescribed in U.S. acute-care hospitals are unnecessary or inappropriate. With the need for healthcare systems and federal agencies to increase their focus on antibiotic stewardship, both providers and pharmacists play a vital role in monitoring safe and appropriate use. Today, VigiLanz, a clinical surveillance company, and IllumiCare, a leading provider of point-of-care technology, announce a partnership to increase visibility within providers’ and pharmacists’ normal workflows around antimicrobial therapy monitoring.

IllumiCare’s Smart Ribbon® is an EMR-agnostic, non-intrusive ribbon of information that hovers over the EMR and provides patient-specific information such as the costs and risks of medications and tests, opioid exposures, and more. The Smart Ribbon displays VigiLanz’s Antimicrobial Stewardship Solution in a more visible, convenient and accessible place in the EMR when the provider or pharmacist is making care decisions. With this ability to respond to context in real-time, the Smart Ribbon only delivers notifications on issues or opportunities that busy clinicians and pharmacists can personally act on. This increases engagement with the VigiLanz insights and saves pharmacists the time and energy often spent tracking down a clinical counterpart to resolve an activation that’s halting the workflow.

“One key element to promoting antimicrobial stewardship is making sure the information is easily accessible to the right clinician or pharmacist when they need it most,” said GT LaBorde, CEO of IllumiCare. “VigiLanz provides real-time information related to safe antibiotic use that can reduce overprescribing or inappropriate prescribing and ultimately, lower costs. By making this information not only easier to see and more actionable, but also appropriately tailored to the person taking the action, antimicrobial stewardship efforts will be more successful.”

Houston Methodist Sugar Land Hospital is the first health system to deploy the VigiLanz clinical surveillance alerts within IllumiCare’s Smart Ribbon. Pharmacists can choose to engage with VigiLanz activations by viewing them, marking them as necessary and providing comments, all within their current workflow in the EMR. One of the most important activations is the visibility of drug-bug mismatches, in which the antimicrobial a patient receives is not adequate for the microbiological organism presumed to be causing the clinical infection. Additionally, the VigiLanz alerts highlight broad antimicrobial use, de-escalation opportunities, and conversion opportunities to move the patient to an antibiotic that has equal efficacy but is less expensive, such as from IV drugs to oral medications.

“Having actionable insights into antimicrobial use is critical; being able to put those insights in front of clinicians and pharmacists at the point of care is industry-leading,” said David Goldsteen, MD, CEO of VigiLanz. “We’re thrilled to be partnering with IllumiCare to deliver our trusted clinical surveillance insights through their Smart Ribbon to those who take action, ensuring safe and appropriate antimicrobial use.”

For more information, visit Illumicare at www.illumicare.com and VigiLanz at www.vigilanzcorp.com